• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    The Radoff-Sudbury Group Reiterates the Need to Elect Directors with Governance, Turnaround and Wellness Industry Experience to LifeVantage's Board of Directors

    11/1/23 6:00:00 PM ET
    $DSAQ
    $EGY
    $FTLF
    $LFVN
    Blank Checks
    Finance
    Oil & Gas Production
    Energy
    Get the next $DSAQ alert in real time by email

    Highlights Radoff-Sudbury Group Nominees Will Bring Differentiated Experience and Fresh Perspectives to the Board

    Notes Leading Independent Proxy Advisory Firms ISS and Glass Lewis Concluded that Boardroom Change is Warranted

    Urges Stockholders to Vote for Dayton Judd, Michael Lohner and Bradley L. Radoff on the BLUE Proxy Card Ahead of the November 6th Annual Meeting

    Bradley L. Radoff and Sudbury Capital Fund, LP (together with their affiliates, the "Radoff-Sudbury Group," "we" or our "Group"), represent the largest stockholder of LifeVantage Corporation (NASDAQ:LFVN) ("LifeVantage" or the "Company"), collectively owning approximately 12.8% of the Company's outstanding stock. Today, the Group issued the following letter to LifeVantage stockholders ahead of the Company's upcoming Annual Meeting of Stockholders (the "Annual Meeting") on November 6, 2023:

    ***

    Fellow Stockholders,

    The Radoff-Sudbury Group represents the largest stockholder of LifeVantage, meaning our interests are squarely aligned with yours. We believe replacing certain long-tenured directors with stockholder-nominated directors who possess CEO-level transformation, wellness industry and corporate governance experience can help ignite a lasting turnaround following a decade of poor performance. Ahead of next week's Annual Meeting, we want to emphasize the opportunity you have to facilitate long-overdue change at LifeVantage by electing the right directors.

    While we attempted to engage privately with the Board of Directors (the "Board") on ideas for creating value and a settlement, we have been met with sustained resistance. The Company made clear it was not open to welcoming new perspectives to the Board until 2027, which we believe is indicative of the tight grip that Chairman Garry Mauro and other over-tenured directors have on LifeVantage. That is why we have invested a significant amount of our time and capital to nominate a minority slate of individuals with highly relevant skillsets to address the Company's most urgent needs.

    As detailed below, we are seeking to remove Chairman Mauro, Michael Beindorff and Darwin Lewis from the Board due to their excessively long tenures, track records of value destruction and lack of relevant experience. We are asking for your support to elect our three independent nominees, who are committed to putting LifeVantage stockholders' long-term interests first.

    Radoff-Sudbury Group Independent Nominee

    Targeted Incumbent LifeVantage Director

    The Case for Supporting Our Group's Independent Nominee

     

    Dayton Judd

     

    • Chairman and CEO of FitLife Brands, Inc. (NASDAQ:FTLF) ("FitLife")
    • Delivered 2,263% in total stockholder returns ("TSR") while CEO of FitLife1
    • Delivered 173% in TSR while serving as a director at RLJ Entertainment, Inc. (NASDAQ:RLJE)2
    • CEO-level turnaround experience
    • Experienced public company board member
    • Consumer wellness product experience
    • Public company financial expertise
    • Audit Chair experience

    Meaningful LifeVantage stockholder with strong track record of value creation

     

     

    Garry Mauro

     

    • 15-year LifeVantage director tenure
    • -58% LifeVantage TSR during tenure as Chair3
    • No prior C-suite experience
    • No prior public board experience
    • No wellness or direct selling experience
    • No capital allocation experience
    • No prior audit experience

    No meaningful stock ownership in LifeVantage and has overseen significant value destruction

     

     

    Experience & Track Record Comparison

     

    • Mr. Judd is an experienced public company CEO and director with a strong track record of value creation, who owns ~6% of LifeVantage stock.
    • Mr. Judd possesses valuable CEO-level turnaround experience, corporate governance and strategic planning acumen and wellness industry expertise, which would be immediately additive in the boardroom.
    • Mr. Mauro has served as Chairman of LifeVantage for 10 years and on the Board for over 15 years. He has failed to effectively oversee the Company and enabled the destruction of significant value over his tenure.
    • Both ISS and Glass Lewis have recommended for Mr. Judd, while ISS has recommended stockholders remove Mr. Mauro.

     

     

    Michael Lohner

     

    • President, CFO and director of Direct Selling Acquisition Corp. (NYSE:DSAQ)
    • Corporate finance and capital allocation expertise
    • C-suite executive
    • Experienced public company board member
    • Experienced investor

    Experienced executive with strong track record of value creation

     

     

    Michael Beindorff

     

    • ~12-year LifeVantage director tenure
    • -44% LifeVantage director tenure TSR4
    • No wellness or direct selling experience
    • No capital allocation experience
    • No prior public board experience
    • No prior audit experience

    No meaningful stock ownership in LifeVantage

     

     

    Experience & Track Record Comparison

     

    • Mr. Lohner has extensive experience as an investor and executive of companies in the direct selling industry, unlike Mr. Beindorff, who possesses no relevant experience.
    • We believe Mr. Lohner's industry experience would help support LifeVantage's go-forward strategy and address recent significant consultant and customer attrition.
    • Additionally, Mr. Lohner would bring valuable experience in the areas of corporate finance and capital allocation, which are necessary to correct course following the value destruction Mr. Beindorff has presided over for nearly 12 years.
    • Notably, Glass Lewis recommended stockholders remove Mr. Beindorff, pointing to his "predominantly misaligned experiences" and role in overseeing the destruction of value during his nearly 12-year tenure.

     

     

    Bradley L. Radoff

     

    • Experienced public company board member
    • Delivered 720% in TSR while serving as a director at Support.com, Inc. (NASDAQ:SPRT)5
    • Delivered 239% in TSR as a director of VAALCO Energy, Inc. (NYSE:EGY, LSE: EGY)))6
    • Consumer goods industry experience
    • Audit Chair experience
    • Successful private investor
    • Private and public engagements have delivered sizable returns for stockholders

    Meaningful LifeVantage stockholder with strong track record of value creation

     

     

    Darwin Lewis

     

    • 6.5-year LifeVantage director tenure
    • -19% LifeVantage director tenure TSR7
    • Former sales and operations executive
    • No wellness or direct selling experience
    • No capital allocation experience
    • No prior audit experience
    • No prior public board experience

    No meaningful stock ownership in LifeVantage

     

     

    Experience & Track Record Comparison

     

    • Mr. Radoff is an experienced investor and public company director with a strong track record of value creation, who owns 6.8% of LifeVantage stock.
    • Mr. Radoff's capital allocation expertise, public board and audit chair experience would be additive to the Board, compared to Mr. Lewis, who lacks prior audit and relevant financial experience – despite serving as LifeVantage's Audit Committee Chair.
    • We believe Mr. Radoff's valuable perspectives and skillsets can help improve the Company's approach to capital allocation to help enhance value for stockholders.

     

    We believe the choice is clear: voting the BLUE Proxy Card for the entire Radoff-Sudbury Group slate can help ensure the Board begins to act on behalf of all LifeVantage employees, consultants, stockholders and stakeholders.

    We sincerely appreciate the thoughtful conversations and feedback we have received from you in recent weeks. If you have any further questions for us or would like to speak directly with our nominees, please contact our proxy solicitor at [email protected].

    Sincerely,

    Bradley L. Radoff

     

    Dayton Judd

     

    Sudbury Capital Fund, LP

     

    ***

    VOTE "FOR" THE HIGHLY QUALIFIED RADOFF-SUDBURY NOMINEES ON THE BLUE PROXY CARD AHEAD OF LIFEVANTAGE'S UPCOMING ANNUAL MEETING ON NOVEMBER 6, 2023.

    ONLY YOUR LATEST DATED VOTE COUNTS. IF YOU VOTED FOR THE COMPANY'S NOMINEES PREVIOUSLY, A LATER DATED VOTE FOR THE RADOFF-SUDBURY NOMINEES WILL OVERRIDE YOUR PRIOR VOTING INSTRUCTIONS.

    IF YOU HAVE ANY QUESTIONS REGARDING HOW TO VOTE, PLEASE CALL SARATOGA PROXY CONSULTING AT (888) 368-0379 OR (212) 257-1311 OR BY EMAIL AT [email protected].

    PLEASE KNOW THAT BOTH YOUR INTERACTION WITH OUR PROXY SOLICITOR AND YOUR VOTING DECISION ARE COMPLETELY CONFIDENTIAL. SIMILARLY, IF YOUR LIFEVANTAGE SHARES ARE HELD WITH A BROKER, YOUR VOTING DECISION IS COMPLETELY CONFIDENTIAL.

    ***

    1 Source: Bloomberg. TSR calculated from February 18, 2018 through October 30, 2023.

    2 Source: Bloomberg. TSR calculated from May 15, 2015 through October 31, 2018.

    3 Source: Bloomberg. TSR calculated from November 13, 2013 through August 10, 2023.

    4 Source: Bloomberg. TSR calculated from January 10, 2012 through August 10, 2023.

    5 Source: Bloomberg. TSR calculated from June 28, 2016 through September 9, 2021.

    6 Source: Bloomberg. TSR calculated from June 25, 2020 through January 28, 2022.

    7 Source: Bloomberg. TSR calculated from February 16, 2017 through August 10, 2023.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231101942914/en/

    Get the next $DSAQ alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DSAQ
    $EGY
    $FTLF
    $LFVN

    CompanyDatePrice TargetRatingAnalyst
    FitLife Brands Inc.
    $FTLF
    3/17/2025$21.00Buy
    Lake Street
    Lifevantage Corporation
    $LFVN
    1/14/2025$35.00Buy
    Craig Hallum
    Lifevantage Corporation
    $LFVN
    12/19/2024$26.00Buy
    Lake Street
    FitLife Brands Inc.
    $FTLF
    9/3/2024$40.00Buy
    ROTH MKM
    VAALCO Energy Inc.
    $EGY
    3/1/2023Buy
    Stifel
    More analyst ratings

    $DSAQ
    $EGY
    $FTLF
    $LFVN
    Financials

    Live finance-specific insights

    See more
    • FitLife Brands Announces First Quarter 2025 Results

      OMAHA, NE, May 15, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2025. Highlights for the first quarter ended March 31, 2025 include: Total revenue was $15.9 million, 4% lower than the first quarter of 2024.  Online sales were $10.6 million, representing 67% of total revenue and down 2% compared to the first quarter of 2024.Gross margin was 43.1% compared to 44.0% during the first quarter of 2024.Net income for the first quarter of 2025 was $2.0 million compared to $2.2 million during th

      5/15/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • VAALCO Energy, Inc. Announces First Quarter 2025 Results

      HOUSTON, May 08, 2025 (GLOBE NEWSWIRE) -- VAALCO Energy, Inc. (NYSE:EGY, LSE: EGY)) ("Vaalco" or the "Company") today reported operational and financial results for the first quarter of 2025. First Quarter 2025 Highlights and Recent Key Items: Reported net income of $7.7 million ($0.07 per diluted share), Adjusted Net Income of $6.3 million ($0.06 per diluted share) and Adjusted EBITDAX(1) of $57.0 million; Produced 17,764 net revenue interest ("NRI")(2) barrels of oil equivalent per day ("BOEPD"), above the high end of guidance, or 22,402 working interest ("WI")(3) BOEPD, toward the high end of guidance;Sold 19,074 NRI BOEPD, toward the high end of guidance;Entered into new rese

      5/8/25 5:04:16 PM ET
      $EGY
      Oil & Gas Production
      Energy
    • VAALCO Energy, Inc. Declares Second Quarter 2025 Dividend

      HOUSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Vaalco Energy, Inc. (NYSE:EGY, LSE: EGY)) ("Vaalco" or the "Company") today announced that it declared its quarterly cash dividend of $0.0625 per share of common stock for the second quarter of 2025 ($0.25 annualized), which is payable on June 27, 2025, to stockholders of record at the close of business on May 23, 2025. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the Board of Directors. George Maxwell, Vaalco's Chief Executive Officer, commented, "We are pleased to announce our second quarter 2025 dividend, marking our 14th consecutive quarterly dividend. We have an

      5/8/25 2:00:00 AM ET
      $EGY
      Oil & Gas Production
      Energy

    $DSAQ
    $EGY
    $FTLF
    $LFVN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Mauro Garry Paul bought $26,338 worth of shares (2,150 units at $12.25), increasing direct ownership by 0.70% to 86,087 units (SEC Form 4)

      4 - Lifevantage Corp (0000849146) (Issuer)

      5/13/25 4:11:14 PM ET
      $LFVN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Ordal Todd bought $3,621 worth of shares (300 units at $12.07), increasing direct ownership by 0.48% to 62,488 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/16/25 8:00:07 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Lingenbrink Matthew bought $36,510 worth of shares (3,000 units at $12.17), increasing direct ownership by 107% to 5,800 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/16/25 8:00:05 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    $DSAQ
    $EGY
    $FTLF
    $LFVN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • FitLife Brands Announces First Quarter 2025 Results

      OMAHA, NE, May 15, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2025. Highlights for the first quarter ended March 31, 2025 include: Total revenue was $15.9 million, 4% lower than the first quarter of 2024.  Online sales were $10.6 million, representing 67% of total revenue and down 2% compared to the first quarter of 2024.Gross margin was 43.1% compared to 44.0% during the first quarter of 2024.Net income for the first quarter of 2025 was $2.0 million compared to $2.2 million during th

      5/15/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • VAALCO Energy, Inc. Announces First Quarter 2025 Results

      HOUSTON, May 08, 2025 (GLOBE NEWSWIRE) -- VAALCO Energy, Inc. (NYSE:EGY, LSE: EGY)) ("Vaalco" or the "Company") today reported operational and financial results for the first quarter of 2025. First Quarter 2025 Highlights and Recent Key Items: Reported net income of $7.7 million ($0.07 per diluted share), Adjusted Net Income of $6.3 million ($0.06 per diluted share) and Adjusted EBITDAX(1) of $57.0 million; Produced 17,764 net revenue interest ("NRI")(2) barrels of oil equivalent per day ("BOEPD"), above the high end of guidance, or 22,402 working interest ("WI")(3) BOEPD, toward the high end of guidance;Sold 19,074 NRI BOEPD, toward the high end of guidance;Entered into new rese

      5/8/25 5:04:16 PM ET
      $EGY
      Oil & Gas Production
      Energy
    • VAALCO Energy, Inc. Declares Second Quarter 2025 Dividend

      HOUSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Vaalco Energy, Inc. (NYSE:EGY, LSE: EGY)) ("Vaalco" or the "Company") today announced that it declared its quarterly cash dividend of $0.0625 per share of common stock for the second quarter of 2025 ($0.25 annualized), which is payable on June 27, 2025, to stockholders of record at the close of business on May 23, 2025. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the Board of Directors. George Maxwell, Vaalco's Chief Executive Officer, commented, "We are pleased to announce our second quarter 2025 dividend, marking our 14th consecutive quarterly dividend. We have an

      5/8/25 2:00:00 AM ET
      $EGY
      Oil & Gas Production
      Energy

    $DSAQ
    $EGY
    $FTLF
    $LFVN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street initiated coverage on FitLife Brands with a new price target

      Lake Street initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $21.00

      3/17/25 8:22:47 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Craig Hallum initiated coverage on Lifevantage with a new price target

      Craig Hallum initiated coverage of Lifevantage with a rating of Buy and set a new price target of $35.00

      1/14/25 8:36:52 AM ET
      $LFVN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Lake Street initiated coverage on Lifevantage with a new price target

      Lake Street initiated coverage of Lifevantage with a rating of Buy and set a new price target of $26.00

      12/19/24 8:39:43 AM ET
      $LFVN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DSAQ
    $EGY
    $FTLF
    $LFVN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Donohue Casey was granted 60,013 shares (SEC Form 4)

      4 - VAALCO ENERGY INC /DE/ (0000894627) (Issuer)

      6/6/25 9:36:18 PM ET
      $EGY
      Oil & Gas Production
      Energy
    • Chief Operating Officer Pruckl Thor was granted 297,739 shares, increasing direct ownership by 170% to 472,731 units (SEC Form 4)

      4 - VAALCO ENERGY INC /DE/ (0000894627) (Issuer)

      6/6/25 9:35:40 PM ET
      $EGY
      Oil & Gas Production
      Energy
    • EVP, Gen. Counsel & Corp. Sect Powers Matthew R was granted 152,011 shares, increasing direct ownership by 280% to 206,260 units (SEC Form 4)

      4 - VAALCO ENERGY INC /DE/ (0000894627) (Issuer)

      6/6/25 9:34:11 PM ET
      $EGY
      Oil & Gas Production
      Energy

    $DSAQ
    $EGY
    $FTLF
    $LFVN
    Leadership Updates

    Live Leadership Updates

    See more
    • FitLife Brands Announces Board Transition

      Omaha, NE, April 28, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced today the resignation of Todd Ordal as a member of the Company's Board of Directors. Mr. Ordal's resignation, effective on April 25, 2025, was part of the Company's ongoing commitment to refresh board composition on a regular basis in accordance with good corporate governance practices and was not the result of any disagreement with the Company's management or the Board of Directors regarding any matter related to the Company or otherwise. On April 25, 2025, the Board of Directors of

      4/28/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • LifeVantage Welcomes Todd Thompson as Chief Information and Innovation Officer

      SALT LAKE CITY, Jan. 16, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, is proud to announce the addition of Todd Thompson as Chief Information and Innovation Officer. Todd brings decades of experience driving transformative technology solutions and business growth for prominent global organizations. "We are thrilled to welcome Todd to the LifeVantage team," said Steve Fife, President and CEO of LifeVantage. "Todd's exceptional track record in technology leadership and his forward-thinking approach will be pivotal as we continue along our growth path

      1/16/25 8:00:00 AM ET
      $LFVN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • LifeVantage Welcomes Rajendran Anbalagan to the Board of Directors; Thanks Erin Brockovich for Her Years of Service

      SALT LAKE CITY, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, announced the appointment of Rajendran Anbalagan to the Company's Board of Directors effective today. The appointment comes after the Board conducted a comprehensive search to identify a candidate with transformational digital skills and identified Mr. Anbalagan as an exceptional choice. "We are very excited to welcome Rajendran Anbalagan to the LifeVantage Board," said Ray Greer, Chairman. "Raj brings extensive technology experience along with a deep understanding of how to lever

      8/26/24 4:05:00 PM ET
      $LFVN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DSAQ
    $EGY
    $FTLF
    $LFVN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Direct Selling Acquisition Corp.

      SC 13G/A - Direct Selling Acquisition Corp. (0001871745) (Subject)

      11/14/24 1:29:57 PM ET
      $DSAQ
      Blank Checks
      Finance
    • Amendment: SEC Form SC 13G/A filed by Direct Selling Acquisition Corp.

      SC 13G/A - Direct Selling Acquisition Corp. (0001871745) (Subject)

      11/13/24 5:41:56 PM ET
      $DSAQ
      Blank Checks
      Finance
    • Amendment: SEC Form SC 13G/A filed by VAALCO Energy Inc.

      SC 13G/A - VAALCO ENERGY INC /DE/ (0000894627) (Subject)

      11/12/24 5:48:11 PM ET
      $EGY
      Oil & Gas Production
      Energy

    $DSAQ
    $EGY
    $FTLF
    $LFVN
    SEC Filings

    See more
    • VAALCO Energy Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - VAALCO ENERGY INC /DE/ (0000894627) (Filer)

      6/6/25 4:56:29 PM ET
      $EGY
      Oil & Gas Production
      Energy
    • FitLife Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

      5/15/25 8:00:17 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 10-Q filed by FitLife Brands Inc.

      10-Q - FITLIFE BRANDS, INC. (0001374328) (Filer)

      5/15/25 7:30:49 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care